Long-Acting ART: Cabotegravir Plus Rilpivirine
Listen to Ian Frank, MD, discuss long-acting HIV treatment with cabotegravir plus rilpivirine for treatment-experienced PWH, including efficacy data, initiation strategies, virologic failure data, and safety information.
Decera Clinical Education Infectious Disease Podcast · Ian Frank MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Ian Frank, MD, discusses long-acting HIV treatment with cabotegravir plus rilpivirine for people with HIV, including:
- Efficacy data with every-8-week dosing
- Real-world use in people with viremia
- Initiation and continuation strategies
- Virologic failure data
- Safety information
Presenter:
Ian Frank, MD
Associate Chief
Division of Infectious Diseases
Professor of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
To download the slides: https://bit.ly/3HX1GGn
To view the full online program: https://bit.ly/3ZjSFhg
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.